| ORIGINAL ARTICLE |
|
| Year : 2016 | Volume
: 37
| Issue : 1 | Page : 36-40 |
|
|
Psychotropic medication-induced sexual dysfunction and its interference with patient's daily performance: a cross-sectional study
Jisha M Lucca M.Pharm 1, Madhan Ramesh1, Dushad Ram2, Jintu Kurian1, Noyal Mathew1
1 Department of Pharmacy Practice, JSS College of Pharmacy, JSS University, Mysore, Karnataka, India
2 Department of Psychiatry, JSS Hospital, Mysore, Karnataka, India
Correspondence Address:
Jisha M Lucca
Department of Pharmacy Practice, JSS College of Pharmacy, JSS University, SS Nagara, Mysore 570 015, Karnataka
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1110-1105.180268
|
|
|
Objectives
There are very few studies, especially in the Indian population, addressing the frequency of sexual dysfunction due to psychotropic medications. Therefore, this study aimed to quantify the frequency of sexual dysfunction and its interference in the patients' daily performance in a hospital-based population taking psychotropic medications.
Materials and methods
This cross-sectional study was conducted in the psychiatric unit of a Tertiary Care Teaching Hospital in South India over a period of 2 years. The Udvalg for Kliniske Undersogelser side effect rating scale was used to determine sexual dysfunction. A global assessment of interference in daily performance due to side effects was also evaluated.
Results
The overall incidence of sexual dysfunction was 20.95%. A higher incidence of sexual dysfunction was observed in women [n = 56 (70.88%)] and in the age group 18-29 years [n = 30 (37.9%)]. Amenorrhea [n = 32 (38.5%)] was the most prominently observed sexual dysfunction, followed by galactorrhea [n = 15 (18.07%)] and decreased sexual desire [n = 14 (16.86%)]. Antipsychotics [n = 54 (65.06%)] constituted the most common class of drug implicated in sexual dysfunction, followed by antidepressants [n = 25 (30.12%)]. Withdrawal of the drug [n = 58 (42%)] was the most common intervention for the management of sexual dysfunction. The majority of reports rated interference in daily performance due to side effects as severe [n = 48 (60.75%)], followed by moderate [n = 26 (32.91%)].
Conclusion
The incidence rate of sexual dysfunction was 20.95%. Amenorrhea and galactorrhea were the two most prominent sexual dysfunctions affecting the patients with psychotropic medications. Thus it is important for all healthcare professionals to acknowledge and encourage discussion as well as the impact of drugs on sexual function. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
